NCT01353742View on ClinicalTrials.gov

Lamivudine and Adefovir Dipivoxil Fixed Dose Combination

PHASE1CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

February 21, 2011

Primary Completion Date

April 12, 2011

Study Completion Date

April 12, 2011

Conditions

Hepatitis B, Chronic

Interventions

DRUG

Lamivudine

100mg tablet

DRUG

Adefovir dipivoxil

10mg tablet

DRUG

Fixed dose combination (Lamivudine and Adefovir dipivoxil)

100mg/10mg capsule

Trial Locations (1)

Unknown

GSK Investigational Site, Shatin, New Territories

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY